Associated British Foods

Business

Conagra Brands: A Value Play or Value Trap? Investors Weigh Short-Term Momentum Against Long-Term Decline

Conagra Brands (CAG) shares have surged recently, closing at $18.51 and sparking renewed investor interest. While short-term momentum appears positive, a deeper look reveals a stark five-year decline in shareholder returns, raising questions about whether the current price represents a genuine opportunity or a fleeting rally.

Feb 2, 2026

Business

LiveWire Group's Long-Term Investors Face Steep 79% Decline as Stock Tumbles

Shareholders in Harley-Davidson's electric motorcycle spinoff, LiveWire Group, have seen their holdings erode dramatically over five years, with a recent $55 million weekly loss adding to the pain. The company's ongoing revenue contraction raises fundamental questions about its path to profitability in the competitive EV market.

Feb 2, 2026

Business

Fat Brands, Twin Hospitality Delisted from Nasdaq as Bankruptcy Fallout Deepens

The parent company of Fatburger and Round Table Pizza, along with its Twin Hospitality spinoff, will be removed from the Nasdaq exchange effective February 4, transitioning to the over-the-counter market following Chapter 11 filings and over $1 billion in debt.

Feb 2, 2026

Business

PepsiCo Veteran: Mentorship and Development Are Key to Unlocking Supply Chain Careers

In an exclusive interview, PepsiCo SVP Darcy Arata highlights how formal mentorship programs and leadership commitment to inclusivity are transforming career pathways in the evolving supply chain sector.

Feb 2, 2026

From Coffee to Cookies: How New Tariffs Are Driving Up Prices on Imported Grocery Staples

Shoppers are bracing for another wave of price increases as new import taxes take effect, targeting a range of everyday items from spirits to seafood. Experts warn the hikes will squeeze household budgets and force tough choices at the supermarket.

Feb 2, 2026

Business

Freedom Capital Bullish on Mama's Creations, Sees National Growth and Innovation Driving Stock to $16

Freedom Capital initiates coverage on Mama's Creations (MAMA) with a Buy rating and a $16 price target, citing the company's expanding national footprint, product innovation, and strong recent earnings as key growth catalysts in the fresh meal sector.

Feb 2, 2026

Business

BMO Stays the Course on Primo Brands, Trims Target Amid Slower Recovery

BMO Capital maintains its Outperform rating on Primo Brands Corporation (PRMB) despite lowering its price target, citing strong premium brand growth and a long-term recovery path for its direct-to-consumer segment.

Feb 2, 2026

Business

Dollar's Steep Slide Signals Global Loss of Confidence in U.S. Economic Leadership

A sustained plunge in the U.S. dollar's value, driven by soaring debt and geopolitical estrangement, threatens higher consumer costs, rising borrowing rates, and a sharp decline in foreign investment, economists warn.

Feb 2, 2026

World

Royal Scandal Deepens: Crown Princess's Son Faces Rape Trial as Epstein Files Revisit Palace Ties

The Norwegian monarchy is rocked by dual crises as Marius Borg Høiby, son of Crown Princess Mette-Marit, stands trial on serious criminal charges, while newly unsealed Jeffrey Epstein documents reveal extensive past connections to the princess.

Feb 2, 2026

Business

Piper Sandler Trims Price Target for Black Diamond Therapeutics Amid Model Review, Despite Recent Clinical Wins

Analyst Piper Sandler has lowered its price target on Black Diamond Therapeutics (BDTX) while maintaining an Overweight rating, following a broad review of its biotech coverage. The adjustment comes even as the company recently reported encouraging Phase 2 data for its lead oncology drug candidate.

Feb 2, 2026

Business

Altimmune Secures Analyst Backing as Pemvidutide Advances Toward Phase 3 MASH Trial

Barclays initiates coverage with an Overweight rating and $20 price target on Altimmune, citing strong fundamentals and pipeline potential. The biotech firm prepares to channel recent offering proceeds toward its pivotal Phase 3 development for metabolic liver disease treatment pemvidutide.

Feb 2, 2026

US

Appeals Court Rejects DOJ Misconduct Complaint Against Federal Judge, Citing Lack of Evidence

A federal appeals court has dismissed a Justice Department misconduct complaint against U.S. District Judge James Boasberg, ruling the government failed to substantiate its allegations regarding the judge's public comments.

Feb 2, 2026

Business

Lexeo Therapeutics Faces Market Skepticism Despite Positive PKP2 Gene Therapy Data

H.C. Wainwright maintains a Buy rating on Lexeo Therapeutics but slashes its price target, citing persistent market doubts over the company's PKP2 cardiomyopathy program despite encouraging early clinical results.

Feb 2, 2026

Business

Barclays Bullish on 4D Molecular Therapeutics, Sees M&A and Pricing Trends as Key Catalysts

Barclays initiates coverage of 4D Molecular Therapeutics with an Overweight rating and a $33 price target, citing a favorable industry backdrop with potential M&A tailwinds and shifting focus away from drug pricing pressures. The gene therapy developer also outlined key clinical milestones expected through 2026.

Feb 2, 2026

Business

Gymshark Founder Ben Francis on Billionaire Status: 'It's Just a Number on Paper'

From delivering pizzas to building a global sportswear empire, Ben Francis's journey to a $1.4 billion net worth is a modern business fable. Yet, in a candid podcast interview, the Gymshark CEO argues that equating self-worth with wealth is a 'wildly unproductive way to live,' offering a rare glimpse into the mindset behind the paper fortune.

Feb 2, 2026

US

Punxsutawney Phil Predicts Six More Weeks of Winter in 140th Annual Groundhog Day Spectacle

The famed Pennsylvania groundhog saw his shadow on Gobbler's Knob, forecasting a prolonged winter season as thousands braved the cold for the iconic ceremony, while meteorologists warn of ongoing cold spells across the eastern U.S.

Feb 2, 2026

Business

Wisconsin Labor Market Shows Resilience Despite January Layoffs Affecting 366 Workers

Seven Wisconsin employers filed WARN notices in January, yet the state's unemployment rate held steady at a low 3.1%. Economists point to a cooling but stable labor market, with significant workforce changes driven by retirements and sectoral shifts.

Feb 2, 2026

Business

Dr. Martens' Five-Year Slump: Shares Plummet 87% as Brand Struggles to Regain Footing

Iconic bootmaker Dr. Martens has seen its market value erode by over £80 million, with shares falling 87% over five years. The prolonged decline raises questions about the brand's strategy in a shifting retail landscape.

Feb 2, 2026

Business

Disney Posts Record Revenue Amid Streaming Spat, Tourism Dip; Stock Slips

The Walt Disney Company announced blockbuster quarterly earnings driven by historic box office and streaming performance, though profits were pressured by a resolved YouTube dispute, rising costs, and a broader slowdown in international travel to U.S. destinations.

Feb 2, 2026

Business

Robert Kiyosaki Sees Market Plunge as a 'Fire Sale,' Positions Cash for Gold, Bitcoin, and Silver

Investor and author Robert Kiyosaki interprets the sharp decline in gold, silver, and Bitcoin as a strategic buying opportunity, contrasting with analysts who warn of potential bear market signals.

Feb 2, 2026